The danger zone: Systematic review of the role of HMGB1 danger signalling in traumatic brain injury

Microglia in the TBI brain: The good, the bad, and the dysregulated

(2016) David J. Loane et al.   EXPERIMENTAL NEUROLOGY

Glycyrrhizin inhibits traumatic brain injury by reducing HMGB1–RAGE interaction

(2014) Yu Okuma et al.   NEUROPHARMACOLOGY

High mobility group box protein-1 promotes cerebral edema after traumatic brain injury via activation of toll-like receptor 4

(2013) Melissa D. Laird et al.   GLIA

Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood

(2013) Henrik Zetterberg et al.   Nature Reviews Neurology

The Role of Markers of Inflammation in Traumatic Brain Injury

(2013) Thomas Woodcock et al.   Frontiers in Neurology

Anti-high mobility group box-1 antibody therapy for traumatic brain injury

(2012) Yu Okuma et al.   ANNALS OF NEUROLOGY

Plasma high-mobility group box 1 levels and prediction of outcome in patients with traumatic brain injury

(2012) Ke-Yi Wang et al.   CLINICA CHIMICA ACTA

Cerebrospinal Fluid Levels of High-Mobility Group Box 1 and Cytochrome C Predict Outcome after Pediatric Traumatic Brain Injury

(2012) Alicia K. Au et al.   JOURNAL OF NEUROTRAUMA

Expression of HMGB1 and RAGE in rat and human brains after traumatic brain injury

(2012) Tie-Lei Gao et al.   Journal of Trauma and Acute Care Surgery

GFAP and S100B in the acute phase of mild traumatic brain injury

(2012) Z. Metting et al.   NEUROLOGY

Beneficial Effects of Ethyl Pyruvate through Inhibiting High-Mobility Group Box 1 Expression and TLR4/NF-κB Pathway after Traumatic Brain Injury in the Rat

(2011) Xingfen Su et al.   MEDIATORS OF INFLAMMATION

The Acute Inflammatory Response in Trauma / Hemorrhage and Traumatic Brain Injury: Current State and Emerging Prospects

(2009) R Namas et al.   Libyan Journal of Medicine